TickerFactsScreenerDevelopers

Gossamer Bio, Inc. (GOSS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$6.65M2018: -$148.99M2019: -$186.14M2020: -$233.96M2021: -$216.12M2022: -$218.59M2023: -$183.76M2024: -$59.92M2025: -$170.73M-$170.73M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$170.73M-184.9%
2024-$59.92M+67.4%
2023-$183.76M+15.9%
2022-$218.59M-1.1%
2021-$216.12M+7.6%
2020-$233.96M-25.7%
2019-$186.14M-24.9%
2018-$148.99M-2139.5%
2017-$6.65M—